Bad Ideas, Good Outcomes, and Thin Melanomas
From Derms on Drugs · · 54 min
This plays from the publisher's own server. We do not host a copy.
Not rated yet
Description
Thin melanomas that behave badly, a surprisingly intriguing role for oxybutynin in HS, and a reminder that some of dermatology’s most trusted assumptions deserve a second look. This week’s 6-pack is all about the exceptions that force us to rethink the rules.